TL;DR
Treating C17.2 cells with Leflunomide before or after oxygen-glucose deprivation to determine its efficacy as a neuroprotection and inhibitor of mitochondrial dysfunction confirmed that the tissue and mitochondrial protein profile of the target cell/tissue are critical for taking advantage of the therapeutic actions of Leflunomide.
AI-generated by Semantic Scholar
Authors
Claire J. M. Curel, Irene Nobeli, Claire Thornton